Mesenchymal stem cell-conditioned media can ameliorate diabetes-provoked endothelial dysfunction by improving mitochondrial function by the SIRT1-dependent PI3K/Akt/AMPK/PGC1α pathway [300]. The gene discussed is SIRT1; the disease is diabetes mellitus.